Regulatory: Pharma
Assistance with Accelerated Review Programs
Our services: program assistance
As part of our regulatory services in pharma, the Alira Health team can:
- Analyze if your product plan qualifies for expedited pathways
- Assist in applying for orphan drug designations and request for expedited pathways, including breakthrough, fast track, accelerated, and priority review
Why choose Alira Health?
As your partner, Alira Health supports your innovation, optimizing product development success every step of the way. Our integrated, collaborative teams provide a lifecycle approach to delivering our services, including:
- Regulatory strategy
- Regulatory intelligence
- Regulatory operations
- Clinical
- Market access